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Abstract
Introduction: The influence of genetic background on the ability to generate induced pluripotent stem cells
(iPSCs) has the potential to impact future applications, but has yet to be examined in detail. The purpose of this
study was to determine if genetic background affects the efficiency of generating iPSCs during early reprograming
as well as the pluripotent stability of the iPSCs during later stages of reprograming.
Methods: Mouse embryonic fibroblasts (MEFs) were isolated from six strains of mice (NON/LtJ; C57BL/6J; DBA/2J;
BALB/cJ; 129S1/SvlmJ; CAST/EiJ) that were selected based on genetic diversity and differences in ability to produce
embryonic stem cell (ESC) lines. MEFs were reprogramed via doxycycline-inducible lentiviral transduction of murine
Oct4, Klf4, Sox2, and c-Myc. Differences in efficiency to generate iPSCs were assessed by comparing the total number of
colonies, the percentage of colonies positive for alkaline phosphatase staining and the percentage of cells positive for
SSEA1. iPSC colonies were expanded to establish doxycycline-independent cell lines whose pluripotency was then
evaluated via ability to form teratomas in NOD.CB17-Prkdcscid/J mice. Proliferation of non-transduced parent MEFs from
each strain was also examined over ten days under conditions that simulated reprograming.
Results: NON/LtJ and CAST/EiJ strains were more efficient than other strains in generating iPSCs for all parameters
measured and parent MEFs from these strains were more proliferative than those from other strains. Doxycycline-
independent iPSC lines were established using standard conditions for all strains except BALB/cJ, which required a
higher concentration (5x) of leukemia inhibitory factor (LIF). iPSCs from all strains were capable of producing
teratomas in NOD.CB17-Prkdcscid/J mice.
Conclusions: The results of this study suggest that genetic background does affect iPSC generation and
pluripotent stability. In addition, our results demonstrate that strain differences in efficiency to generate iPSCs
during the early stages of reprograming are correlated with those observed in proliferation of parent MEFs. These
findings have important implications both for future iPSC applications as well as for future investigation into
determining the genes responsible for reprograming efficiency and stability.
Introduction
The induced pluripotent stem cell (iPSC) field continues
to make rapid advances in terms of optimizing repro-
graming methods to circumvent clinical safety issues and
characterization of the genetic and epigenetic composi-
tion of established iPSC lines [1-4]. The influence of
genetic background on the ability to generate iPSCs, as
well as the stability and quality of derived iPSCs for
downstream applications, also has the potential to impact
the future applications. However, the role of genetic
background has yet to be examined in significant detail.
The effect of genetic background on pluripotency has
precedence in mice; it is well documented that there are
dramatic strain differences in ability to produce embryo-
nic stem cell (ESC) lines [5-8].
Many of the mouse iPSC studies to date have used
mouse embryonic fibroblasts (MEFs) from transgenic
mice of an undefined or hybrid background [9], or have
used MEFs or tail tip fibroblasts (TTFs) derived from ani-
mals originally produced from hybrid ESCs [9-16]. Few
studies have used MEFs or TTFs from a pure inbred
strain [17-19]. To our knowledge, only one study to date
has directly compared the ability of two different inbred
strains to generate iPSCs [17]. In this study, Hanna et al.
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found that MEFs from NOD/ShiLtJ mice, a strain pre-
viously considered nonpermissive for ESC derivation,
were capable of generating iPSCs, but that these iPSCs
were dependent on exogenous transgene expression
unlike the iPSCs derived from control 129Sv/Jae MEFs
[17]. The authors determined that the NOD/ShiLtJ iPSCs
were dependent upon ectopic expression of either KLF4
or c-MYC using constitutive lentiviruses, and that the
cells were able to overcome this factor dependence when
cultured in media supplemented with any of the follow-
ing proteins or small molecules: WNT3a, which pro-
motes iPSC derivation in the absence of c-MYC [20];
CHIR99021, a GSK3b inhibitor; or Kenpaullone, a
GSK3b and CDK1/cyclin B inhibitor which has been
shown to replace KLF4 during iPSC reprograming
[17,21]. As the authors concluded, these results suggest
that genetic background can affect the pluripotent stabi-
lity of iPSCs and that reprograming and culture condi-
tions may have to be modified for certain strains [17].
The purpose of this study was to determine if genetic
background affects the efficiency of generating iPSCs dur-
ing early reprograming as well as the pluripotent stability
of the iPSCs during later stages of reprograming. We
chose six different inbred strains of mice to examine,
based on their genetic diversity [22-24] and on their differ-
ences in ability to produce ESC lines [5-8]. These six
strains included five classical laboratory strains (NON/LtJ,
C57BL/6J, DBA/2J, BALB/cJ, and 129S1/SvlmJ) and one
wild-derived inbred strain (CAST/EiJ) (Figure 1). Because
129-derived substrains such as 129S1/SvlmJ support facile
ESC line derivation [5-8], while both C57BL/6J and BALB/
cJ mice do not [5,8], we reasoned that these strains would
be useful for assessing potential differences in reprogram-
ing efficiency. In addition, three of the strains (C57BL/6J,
129S1/SvlmJ, and CAST/EiJ) are progenitors of the Colla-
borative Cross that is proving effective for analyzing com-
plex genetic phenotypes [25,26]. Knowledge on the
potential differences between these strains in their ability
to generate iPSCs and their pluripotent stability might
therefore be amenable to genetic analysis.
In this study, we show that iPSC lines can be generated
from all six of the strains examined using a lentiviral
reprograming system [27-29] and that these cell lines are
capable of forming teratomas in NOD.CB17-Prkdcscid/J
mice. We demonstrate, however, that there are strain dif-
ferences in efficiency of iPSC induction, growth, and main-
tenance requirements, and that these strain differences
correlate with proliferative ability of the parental MEFs.
Materials and methods
Mice
Male and female mice from all six strains examined
(NON/LtJ; C57BL/6J; DBA/2J; BALB/cJ; 129S1/SvlmJ;
CAST/EiJ ) were purchased from The Jackson
Laboratory (Bar Harbor, ME, USA). For each strain,
breeder trios were established for timed matings such
that embryonic day-13.5 embryos could be collected and
processed to generate MEFs. NOD.CB17-Prkdcscid/J
mice, used for teratoma formation assays, were also pur-
chased from The Jackson Laboratory. The use of mice
in this study was approved by the Institutional Animal
Care and Use Committee of Cornell University.
MEF culture
Embryonic day-13.5 embryos were isolated from the uteri
of pregnant mice, lavaged with phosphate buffered saline
(PBS), and eviscerated. Each embryo was then gently
homogenized in MEF media comprising high glucose
Dulbecco’s modified eagle’s medium (DMEM) containing
10% fetal bovine serum (FBS), penicillin (100 units/mL),
and streptomycin (100 units/mL) and the resultant cell
suspension was transferred to a 100-mm tissue culture
plate and incubated at 5% CO2, 90% humidity, and 37°C.
The plates were washed with PBS and the media changed
daily until the MEFs were confluent, at which time they
were trypsinized, resuspended in freeze media compris-
ing DMEM with 10% FBS and 10% dimethyl sulfoxide
(DMSO), and cryopreserved until further use. All experi-
ments were performed using MEFs derived from two dif-
ferent embryos for each strain.
Lentiviral constructs
Lentiviral vectors for doxycycline-inducible transgene
expression were constructed as previously described
[27-29] using an FUW-based plasmid with a tetracycline
operator (TetO) and a constitutive cytomegalovirus
(CMV) promoter. Briefly, the viral packaging plasmids
psPAX2 and pMD2.G (Addgene 12260 and 12259, Cam-
bridge, MA, USA) as well as the plasmids encoding the
reverse tetracycline transactivator (M2rtTA; Addgene
20342, Cambridge, MA, USA) and the mouse factors
Oct4, Sox2, Klf4 and c-Myc (Addgene 20323, 20326, 20322
and 20324 respectively, also Cambridge) were purified
from bacterial cultures. The vectors were then prepared by
co-transfecting the viral packaging plasmids with plasmids
encoding the reverse tetracycline transactivator and the
reprograming factors into 293T cells using the FuGENE®6
Transfection Reagent (Roche Applied Science, Indianapo-
lis, IN, USA). Viral supernatants were collected at 48 and
72 hours, concentrated using an Amicon Ultra-15 centri-
fugal filter unit with an Ultracel-30 membrane (Millipore,
Billerica, MA, USA), filtered through a 0.45 um filter, and
stored in liquid nitrogen until used.
Reprograming of MEFs and iPSC culture
Passage 2 (P2) MEFs from each strain were seeded onto
gelatin-coated tissue culture plates at a density of 6.75 ×
103 cells/cm2 in MEF media and allowed to adhere for
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24 hours [27]. The culture media was then replaced
with fresh MEF media supplemented with the viral
supernatant described above. Following 24 hours of
incubation with the viral supernatant, the culture media
was changed to ESC media (KnockOut™ DMEM
(Gibco, Grand Island, NY, USA) supplemented with
15% KnockOut™ Serum Replacement (Gibco), recombi-
nant LIF, MEM non-essential amino acids solution (100
μm), 2 mM GlutaMAX™(Gibco), 0.1 mM 2-mercap-
toethanol, penicillin (100 units/mL), streptomycin (100
units/mL), and doxycycline (2 μg/mL; Sigma, St. Louis,
MO, USA)). Cells destined for flow cytometric analysis
and for expansion were kept on original 6-well plates
while cells destined for alkaline phosphatase (AP) stain-
ing and colony counting were trypsinized and passaged
onto gelatin-coated 60 mm tissue culture plates seeded
with feeder cells (Cs irradiated C57BL/6J × 129S1/
SvImJ1 MEFs) prior to the start of reprograming with
doxycycline. For all plates, ESC media was refreshed
daily during reprograming
AP staining and colony counting
AP staining was performed directly on the 60-mm plates
using the Vector Red Alkaline Phosphatase Substrate Kit
(Vector Laboratories, Burlingame, CA, USA) according
to the manufacturer’s directions. Both the number of
Figure 1 Mouse family tree. The seven mouse groups as described as by Petkov et al. [22] with the strains examined in this study circled in
red. Group 1, Bagg albino derivatives; Group 2, Swiss mice; Group 3, Japanese and New Zealand inbred strains; Group 4, C57/58 strains; Group 5,
Castle’s mice; Group 6, CC Little’s DBA and related strains; Group 7, wild-derived strains. Modified from Petkov et al. and reprinted with
permission [22]. The length and angle of the branches were optimized for printing and do not reflect the actual evolutionary distances between
strains.
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AP-stained colonies and the total number of colonies on
the plates were quantified using bright field microscopy
at 100× magnification. Colonies were identified based
on the following morphological criteria: well defined-
border, three-dimensionality, and tightly packed cells. A
grid system was used on the plates to facilitate colony
counting. Each plate was counted twice and the mean
number of AP-stained colonies and the mean total num-
ber of colonies was determined. The percentage of AP
stained colonies was determined by dividing the mean
number of AP-stained colonies by the mean total num-
ber of colonies and then multiplying by one hundred.
Flow cytometric analysis
Cells from the 6-well primary transformation plates were
trypsinized, washed with PBS, fixed in 4% paraformalde-
hyde, washed again, and resuspended in blocking buffer
(TBS buffer, 0.1% Triton X-100, and 1% BSA) overnight
at 4°C. The cell pellet was then washed, resuspended in
unconjugated primary antibody for 1 hour at 4°C,
washed, and resuspended in a secondary fluorescent-con-
jugated antibody for an additional 1 hour at 4°C. Cells
were resuspended in blocking buffer and analyzed on a
BD LSR II (Becton Dickinson Immunocytometry Sys-
tems, San Jose, CA, USA) flow cytometer and FACSDiva
software (Becton Dickinson). Data were collected on 1 ×
104 cells. Double staining with primary antibodies against
SSEA1 (Millipore MAB4301, Billerica, MA, USA) and
LIN28 (Abcam Inc. ab46020, Cambridge, MA, USA) with
respective fluorescein isothiocyanate (FITC) (Southern-
Biotech 1010-02, Birmingham, AL, USA) and PerCP-
Cy5.5 (Santa Cruz Biotechnologies sc-45101, Santa Cruz,
CA, USA) conjugated secondary antibodies was per-
formed with resultant quadrant statistics including per-
centage of positive cells in each quadrant. Calibration of
the flow cytometer and setting of gates was performed
using non-transduced P2 MEFs as negative controls and
established 1-A4 (C57BL/6J ×129S1/SvlmJ) iPSCs and
v6.4 (C57BL/6J × 129S4/SvJae) ESCs (530 You,Y. 1998)
as positive controls. The 1-A4 iPSC line was generated in
our laboratory and validated via teratoma formation in
NOD.CB17-Prkdcscid/J mice and ability to generate germ-
line chimeras through blastocyst injection.
iPSC line generation
iPSC colonies from 6-well primary transformation plates
were picked with pipette tips into individual wells of
96-well tissue culture plates containing trypsin. The tryp-
sin was neutralized with DMEM and 10% FBS, and the
cells within each well were then transferred to individual
wells of 96-well tissue culture plates seeded with feeder
cells in ESC media and expanded. Doxycycline was
removed from the media at the 6-well plate stage (around
P7) in order to establish doxycycline-independent cell
lines from each strain. The cells were then further
expanded (P10 to P15) in order to reach the cell numbers
necessary for teratoma formation assays and for cryopre-
servation of stock from each strain.
Teratoma formation and histological analysis
iPSCs from one doxycycline-independent cell line from
each strain were trypsinized, pelleted and suspended at
1 × 107 cells/mL in MEF media, then 150μl of the cell sus-
pension (1.5 × 106 cells) was injected subcutaneously into
the flank of a NOD.CB17-Prkdcscid/J mouse. For each
strain, six injections were performed in 3 NOD.CB17-
Prkdcscid/J mice (both flanks of each mouse were injected).
Four to five weeks post-injection, tumors were surgically
dissected, fixed in 4% paraformaldehyde, embedded in par-
affin, sectioned, and stained with hematoxylin and eosin.
All histologic sections were reviewed by a board-certified
veterinary pathologist (TLS.) for teratoma formation.
MEF proliferation assays
Proliferation of non-transduced parent P2 MEFs from
each strain was examined every 2 days over a total of
10 days. We seeded 1.9 × 105 MEFs on each 60 mm tis-
sue culture plate to be cultured and later harvested at
the indicated time points to perform cell counts. MEFs
were maintained in standard MEF media for the first
24 hours and then the media was changed to ESC
media supplemented with doxycycline to simulate repro-
graming conditions for the remainder of the assay.
Assays were performed using MEFs derived from two
different embryos for each strain.
Results and discussion
Strain differences in efficiency to generate iPSCs are
manifested in the early stages of reprograming
In order to assess potential strain background effects on
iPSC generation during early reprograming, the primary
transformation and 60 mm plates were evaluated for the
total number of colonies, the percentage of colonies posi-
tive for AP staining, and the percentage of cells positive
for SSEA1 and LIN28 expression. On both the 60-mm
plates in which the cells were used for AP staining and
colony counting and the 6-well primary transformation
plates in which the cells were used for flow cytometric
analysis, gross differences in the generation of iPSC colo-
nies were observed such that cells had to be stained and
counted, or harvested for flow cytometry, after only
8 days of reprograming in order to avoid overconfluency
of cells from the most efficient strains (Figure 2A). This
time point was much earlier than expected based on the
doxycycline-inducible lentiviral reprograming system lit-
erature in which colonies are generally passaged or
picked off of primary transformation plates around 13 to
21 days for expansion and/or evaluation [27-29], and
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stresses the differences that can be observed when using
strains of diverse genetic backgrounds. Because the iPSCs
were harvested at this very early time point of 8 days, the
resultant LIN28 expression was negative in the iPSCs
from all six strains and only SSEA1 expression was
included in the final analysis. This finding is consistent
with the literature in which LIN28 is used as a marker
for more established iPSCs and ESCs [30-32] as con-
firmed by our control iPSC (1-A4) and ESC (v6.4) lines.
During early reprograming, MEFs from all of the
strains formed cell colonies exhibiting typical iPSC
morphology that were AP-positive within 8 days after the
start of reprograming. However, the total number of
colonies and the percentage of AP-positive colonies var-
ied dramatically between the strains. Notably, NON/LtJ
and CAST/EiJ strains were more efficient than other
strains (Figures 2B and 2C). Similarly, the percentage of
cells positive for SSEA1 varied between the strains but
paralleled the previous two parameters with NON/LtJ
and CAST/EiJ having the highest percentage (Figure 2D).
As expected, the percentage of cells positive for SSEA1
was low (between 0.11 and 8.64%) at this early time point
Figure 2 Strain differences during early iPSC reprograming. Gross strain differences in efficiency to generate induced pluripotent stem cell
(iPSC) colonies were observed after 8 days of mouse embryonic fibroblast (MEF) reprograming as visualized in these photographs with alkaline
phosphatase (AP) staining (A). Strain differences were quantified by total number of colonies (B), percentage of colonies positive for alkaline
phosphatase staining (C) and percentage of cells positive for SSEA-1 (D). NON/LtJ and CAST/EiJ strains were consistently more efficient than
other strains in generating early iPSCs. These differences were not believed to be due to strain differences in MEF transducibility, as
demonstrated by the percentage of cells positive for green fluorescent protein (GFP) on day 8 following transduction with a lentiviral GFP vector
(E). Experiments were performed using MEFs derived from 2 different embryos for each strain (data presented as mean ± SD).
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of 8 days after the start of reprograming for all strains.
Using the same doxycycline-inducible lentiviral repro-
graming system, Brambrink et al. previously demon-
strated that SSEA1 expression appears between 3 and 9
days of reprograming, whereas AP activity appears within
3 days of reprograming [27]. Brambrink et al. also
showed that after 9 days of reprograming, about 7% of
AP-positive cells were also SSEA1-positive [27]. This per-
centage of SSEA1-positive cells is consistent with our
findings.
To ensure that the differences amongst strains in
reprograming efficiency were not due to differences in
lentiviral infection, P2 MEFs were seeded on 6-well plates
at the same density as they were for reprograming, trans-
duced with a lentiviral green fluorescent protein (GFP)
vector (Addgene 14883, Cambridge, MA, USA) and
maintained under reprograming conditions. After 8 days,
the cells were trypsinized and the percentage of GFP-
positive cells was determined using flow cytometry. The
percentage of GFP-positive cells was very similar for all
strains, ranging from 35.10 ± 5.23% (mean ± SD) for
NON/LtJ MEFs to 51.25 ± 0.21% for 129S1/SvImJ1
MEFs, suggesting that the strain differences in efficiency
to generate iPSCs were not due to strain differences in
MEF transducibilty (Figure 2E).
Differences in proliferation of parent non-transduced
MEFs correlate with differences in efficiency to generate
iPSCs during early reprograming
Proliferation of non-transduced parent P2 MEFs was
examined every 2 days over a total of 10 days in order to
determine if genetic differences in MEF proliferation
could potentially be affecting the efficiency of iPSC gen-
eration (Figure 3A). Strain differences in MEF prolifera-
tion were observed over the 10 day period and a positive
correlation was found between MEF growth rate and effi-
ciency to generate iPSCs during early reprograming. This
is demonstrated in Figure 3B where MEF growth rate
and total number of colonies positive for AP staining are
compared with a resultant r2 value of 0.75. In particular,
NON/LtJ and CAST/EiJ MEFs were the most prolifera-
tive and most efficient in generating iPSCs while DBA/2J
MEFs were the least.
Interestingly, fibroblasts capable of increased prolifera-
tion through Trp53 deletion have increased iPSC genera-
tion efficiency [33-35]. It is possible that MEFs of the most
efficient strains found in this study, NON/LtJ and CAST/
EiJ, have a reduced rate of senescence compared to the
other strains, which is allowing for more effective repro-
graming. The fact that the most proliferative MEFs were
of the CAST/EiJ strain is also of interest as this wild-
derived inbred strain is the most genetically distinct strain
that we examined.
The finding of this study that cellular proliferation rate is
correlated with iPSC generation efficiency is consistent
with those of Ruiz et al. in which the induction of cellular
proliferation (through downregulation of pRb) increased
human iPSC reprograming efficiency [36]. In that study,
Ruiz et al. also elegantly demonstrated that cell cycle
arrest (through induction of the arrest inducers p15, p16,
or p21) inhibits reprograming and actually drives iPSCs
towards irreversible differentiation [36]. A potential
Figure 3 Strain differences in mouse embryonic fibroblast (MEF) proliferation. Strain differences in MEF proliferation were observed over
10 days and were well correlated with the observed strain differences in efficiency to generate induced pluripotent stem cells (iPSCs) during
early reprograming. Non-transduced parent P3 MEFs from each strain were seeded at 1.9 × 105 cells per 60-mm tissue culture plate on day 0
and then counted every 2 days over a total of 10 days (A). MEFs were maintained in standard MEF media for the first 24 hours after which the
media was changed to embryonic stem cell (ESC) media supplemented with doxycycline to simulate reprograming conditions. MEFs derived
from two different embryos were evaluated for each strain (data presented as mean ± SD). The growth rate of the MEFs from each strain was
determined from the slope of the linear regression curve fitted to the data set in (A) for each strain. The growth rate of each strain was then
plotted against the total number of colonies positive for alkaline phosphatase (AP) staining and a line of best fit determined, revealing a
moderately strong positive correlation between iPSC generation efficiency and MEF proliferation as indicated by the r2 value (B).
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follow-up study to this one in order to further elucidate
the mechanisms behind the differences in genetic back-
ground effects on iPSC efficiency would be to alter the cel-
lular proliferation of the MEFs for each strain, either
through induction or arrest, and then examine the iPSC
generation efficiency.
BALB/cJ iPSCs require a higher concentration of LIF than
other strains for cell line expansion and doxycycline
independence
In order to determine if genetic background affects the
pluripotent stability of iPSCs during later stages of
reprograming, iPSC lines from all six strains were estab-
lished and further expanded without doxycycline supple-
mentation. Doxycycline-independent iPSC lines could be
established using our standard conditions and ESC media
for all strains except BALB/cJ, which were established only
when supplemented with a higher concentration (5×) of
leukemia inhibitory factor (LIF). This finding suggests that
BALB/cJ iPSCs may have reduced pluripotent stability and
is consistent with the BALB/cJ ESC literature in which
BALB/cJ ESC lines were established only when using a 5×
higher concentration of LIF than that needed for other
strains [5-7]. The mechanism behind this requirement for
Figure 4 Pluripotency of induced pluripotent stem cells (iPSCs) derived from mouse embryonic fibroblast (MEFs) of each strain.
Doxycycline-independent cell lines from all the strains were capable of producing teratomas in NOD SCID mice by 5 weeks post-injection as
shown in these histologic images, all of which are stained with hematoxylin and eosin and viewed at 200× magnification. (A) NON/LtJ; (B)
C57BL/6J; (C) BA/2J; (D) BALB/cJ; (E) 129S1/SvlmJ; (F) CAST/EiJ. Tissues from all three germ layers were identified on each section as indicated by
the labels: Ect, ectoderm; Mes, mesoderm; End, endoderm.
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increased LIF supplementation in BALB/cJ cells has yet to
be identified.
Doxycycline-independent cell lines from all strains are
capable of producing teratomas in SCID mice
Doxycycline-independent cell lines from all the strains
were capable of producing teratomas in NOD.CB17-
Prkdcscid/J mice by 5 weeks post injection, thereby demon-
strating pluripotency (Figure 4). For all strains, the cell
lines were between P10 and P15 and were the initial cell
lines chosen for the teratoma assay. None of the cell lines
from any of the strains required a repeat set of injections
or the assay to be repeated with a different cell line.
iPSC lines in this study were not evaluated for their
ability to generate chimeras or for germline competence,
making direct comparison to the ESC literature on the
effect of genetic background difficult beyond the finding
of reduced pluripotent stability already discussed for the
BALB/cJ strain. While the 129S1/SvlmJ strain was mod-
erately efficient in generating IPSCs compared to the
other strains in this study and the 129S1/SvlmJ iPSC
line was readily able to form teratomas in NOD.CB17-
Prkdcscid/J mice, a conclusion cannot be drawn from
these data as to whether or not this strain is as useful
for generating iPSCs as it has been shown to be for gen-
erating ESCs for transgenic applications [6,7]. In addi-
tion, the two most efficient strains in this study, NON/
LtJ and CAST/EiJ, are strains that have not been exam-
ined for their ability to generate ESCs, making them
intriguing candidates for future studies.
Conclusions
Our comparison of six different inbred mouse strains
has revealed that genetic background does affect both
the efficiency of generating iPSCs during the early stages
of reprograming as well as the pluripotent stability of
the cells during later stages of reprograming. These
findings suggest that genetic background must be con-
sidered when interpreting results of iPSC studies in the
literature and that iPSC derivation may need to be cus-
tomized for different strains. In addition, our findings
suggest that the proliferation rate of the fibroblasts is
positively correlated with iPSC generation, suggesting a
possible simple laboratory screening parameter to pre-
dict iPSC generation efficiency.
The two most efficient strains in this study, NON/LtJ
and CAST/EiJ, may prove useful in the future for deriv-
ing iPSCs for transgenic purposes, as iPSCs from these
strains appear to be robust. One limitation to this study,
however, was that we did not evaluate the iPSCs lines
for their ability to generate chimeras and for germline
competence. This information is essential for ultimately
determining which strain may be most beneficial for
transgenic applications.
In conclusion, we have shown that there are strain dif-
ferences in efficiency to generate iPSCs during the early
stages of reprograming and that these strain differences
are correlated with those observed in proliferation of
parent MEFs. We have also shown that there are strain
differences in pluripotent stability as far as ability to
expand iPSC lines and achieve doxycycline indepen-
dence. These findings have important implications both
for future iPSC applications as well as for future investi-
gation into determining the genes responsible for repro-
graming efficiency and stability. It is possible that the
Collaborative Cross, of which three of the strains exam-
ined in this study are progenitors, could be used to
identify such genes.
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